In 786‐O cells, OLFML2B knockdown greatly inhibited the growth rate of xenograft tumors (Figure 9E,F), and the tumor weight in the OLFML2B knockdown group was significantly lower compared to the control group (Figure 9G). This evidence concerns the gene OLFML2B and neoplasm.